Abstract:Process‐level data from alcohol reduction interventions targeting individuals with chronic liver disease are limited. Changes in psychological processes and WHO alcohol risk levels from HepART were analyzed. Changes in 4 of 12 psychological processes (SOCRATES Taking Steps, Ambivalence, Recognition, and Alcohol Reduction Strategies) were significantly associated with change in WHO risk levels. Alcohol interventions targeting at‐risk patients with liver disease are effective. However, findings provide mixed support for relationships between changes in theoretically informed psychological processes and alcohol outcomes. Background There is a lack of randomized controlled trials of behavioral interventions and process‐level research related to alcohol reduction among patients with chronic liver disease (e.g., hepatitis C viral (HCV) infection). We conducted a process‐level, secondary analysis of the Hepatitis C‐Alcohol Reduction Treatment (HepART) trial to investigate the association between change in psychological processes posited by the Integrated Behavioral Model (IBM) and change in World Health Organization (WHO) drinking risk levels. Methods Patients with HCV who consume alcohol were recruited from hepatology clinics and received provider‐delivered SBIRT (Screening, Brief Intervention, Referral to Treatment) or SBIRT+ 6 months of co‐located alcohol counseling. Treatment arms were combined for this analysis because no between‐group differences were found. At baseline and 6 months, the timeline followback method was used to determine alcohol risk levels according to the 2000 WHO risk categories (based on average grams of alcohol per day). Changes in alcohol consumption and WHO risk levels were quantified and regressed on change in individual psychological processes (e.g., readiness, self‐efficacy, motives, attitudes, and strategies) from baseline to 6 months. Results At the baseline assessment, 162 participants were classified as abstinent (5%), low (47%), moderate (16%), high (19%), or very high (13%) WHO risk levels. At 6 months, 38% remained at the same risk level and 48% decreased by at least one level. In univariate analyses, changes in 7 of 12 psychological processes were associated with change in risk levels. Adjusted multivariate analyses demonstrated that change in four processes were significantly associated with change in risk levels, including SOCRATES Taking Steps, Ambivalence, and Recognition scores and alcohol reduction strategies. Conclusions These findings demonstrate significant reductions in quantitative indices of alcohol consumption following opportunistic alcohol interventions in patients with HCV. However, results provided mixed support for associations between change in IBM psychological processes and alcohol consumption.

[The sex-trapping of Sterrha biselata (Hufn.) (Lepidoptera Geometridae, Sterrhinae) by acetoxy-1 dodecadiens-7 E, 9Z, the sex pheromone of Lobesia botrana (Schiff.) (Lepidoptera Tortricidae, Olethreutinae)].

Impact of Alcohol Drinking on the Clinical Progression and Outcome of Patients with Chronic Hepatitis C

Typing of Aeromonas strains from patients with diarrhoea and from drinking water.

Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection

High Hepatitis C Cure Rates Among Patients With Alcohol Use at a Safety-Net Hepatitis C Clinic

The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the DAA Era

Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis: Systematic review and meta‐analysis

Psychological processes and alcohol reduction in patients with chronic hepatitis C: Results from the HepART trial

Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis

Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis

Hepatology consultation is associated with decreased early return to alcohol use after discharge from an inpatient alcohol use disorder treatment program

Trauma is a recurrent disease.

Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis

Alcohol use disorder in community management of chronic liver diseases

[Characteristics of liver damage in children with mucoviscidosis].

Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis

Alcohol as a risk factor for mortality in liver transplant patients in Sweden

Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)

Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care

Early detection of liver disease in patients with alcohol use disorder improves long-term abstinence

Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium